New LMP NEJM publication assesses effectiveness of kidney disease therapies

Congratulations to LMP Renal Pathologist, Dr. Carmen Avila-Casado on her recent publication in the New England Journal of Medicine.

The paper is titled, Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy, and assesses the effectiveness of two different therapies in the treatment of Membranous Nephropathy kidney disease.  

In addition to Dr. Avila-Casado’s contributions, she emphasized that the work of the Pathology Research Program (PRP) lab was fundamental in the study through its excellent histology and staining services.

The publication can be read online in its entirety here>>

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create a free website or blog at

Up ↑